InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
5
T+90 hit rate
33%
T+90 mean return
-5.2%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Prout Samantha, Directeur Comptable Principal. Director active across 1 company, notably Amicus Therapeutics, INC.. Aggregated, 17 filings have been published. Breakdown: 0 buy · 5 sells. Total volume traded: €603k. History available since 23 August 2021. The latest transaction was disclosed on 27 April 2026 (Disposition). Regulator: SEC (Form 4). All data is free.
Declarations17 total
125,951 shares@ US$14.500.039% mcap52.0% of flowCommon StockSEC:0001193125-26-182259:0
3,443 shares@ US$14.272.9% of flowCommon StockSEC:0001193125-26-005045:0
12,240 shares@ US$14.2710.3% of flowCommon StockSEC:0001193125-26-005045:1
27,416 shares0Common StockSEC:0000950170-25-020043:0
3,443 shares@ US$9.312.2% of flowCommon StockSEC:0000950170-25-002428:0
7,027 shares@ US$10.664.9% of flowCommon StockSEC:0000950170-24-044881:0
1,337 shares@ US$14.001.2% of flowCommon StockSEC:0000950170-24-003440:1
30,767 shares@ US$14.002927.4% of flowCommon StockSEC:0000950170-24-003440:0
8,142 shares@ US$13.537.0% of flowCommon StockSEC:0000950170-24-002578:0
23,356 shares@ US$14.1920.8% of flowCommon StockSEC:0000950170-24-001295:0
7,659 shares@ US$14.00036.8% of flowCommon StockSEC:0000950170-23-073629:0
7,432 shares@ US$12.776.1% of flowCommon StockSEC:0001209191-23-046747:0
2,376 shares@ US$10.041.5% of flowCommon StockSEC:0001209191-23-045479:0
1,980 shares@ US$10.040.0004% mcap13.1% of flowCommon StockSEC:0001209191-21-055206:0
1,980 shares@ US$10.041.2% of flowCommon StockSEC:0001209191-21-055206
5,045 shares@ US$11.000.0010% mcap36.9% of flowCommon StockSEC:0001209191-21-053351:0
5,045 shares@ US$11.003.3% of flowCommon StockSEC:0001209191-21-053351
17 of 17 declarations
About Prout Samantha
Samantha Prout is the Principal Accounting Officer at Amicus Therapeutics, Inc. In this role, she is responsible for managing financial reporting and accounting compliance for the company.
